Gastrin releasing peptide compounds

Details Gastrin releasing peptide compounds Gastrin releasing peptide compounds

2004-04-20

2009-11-03

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C424S001110, C424S001650, C424S001690, C424S009600

Reexamination Certificate

active

07611692

ABSTRACT:
New and improved compounds for use in diagnostic imaging or therapy having the formula M—N—O—P—G, wherein M is an optical label or a metal chelator (in the form complexed with a metal radionuclide or not), N—O—P is the linker, and G is the GRP receptor targeting peptide. Methods for imaging a patient and/or providing radiotherapy or phototherapy to a patient using the compounds of the invention are also provided. Methods and kits for preparing a diagnostic imaging agent from the compound is further provided. Methods and kits for preparing a radiotherapeutic agent are further provided.

REFERENCES:
patent: 4885363 (1989-12-01), Tweedle
patent: 4988496 (1991-01-01), Srinvasan et al.
patent: 5068222 (1991-11-01), Camble et al.
patent: 5084555 (1992-01-01), Coy et al.
patent: 5217955 (1993-06-01), Bogden et al.
patent: 5244883 (1993-09-01), Cai et al.
patent: 5369094 (1994-11-01), Schally et al.
patent: 5410018 (1995-04-01), Spindel et al.
patent: 5428018 (1995-06-01), Edwards et al.
patent: 5428019 (1995-06-01), Edwards et al.
patent: 5474756 (1995-12-01), Tweedle et al.
patent: 5534497 (1996-07-01), Verbruggen
patent: 5620955 (1997-04-01), Knight et al.
patent: 5620959 (1997-04-01), Leban et al.
patent: 5686410 (1997-11-01), Albert et al.
patent: 5833985 (1998-11-01), Ball et al.
patent: 5834433 (1998-11-01), Krstenansky
patent: 5965695 (1999-10-01), Simon et al.
patent: 5981504 (1999-11-01), Buchsbaum et al.
patent: 6075121 (2000-06-01), Simon et al.
patent: 6191290 (2001-02-01), Safavy
patent: 6200546 (2001-03-01), Hoffman et al.
patent: 6307017 (2001-10-01), Coy et al.
patent: 6866837 (2005-03-01), Reubi et al.
patent: 6921526 (2005-07-01), Hoffman et al.
patent: 7147838 (2006-12-01), Hoffman et al.
patent: 7226577 (2007-06-01), Cappelletti et al.
patent: 2002/0164287 (2002-11-01), Rajagopalan et al.
patent: 2002/0176819 (2002-11-01), Hoffman et al.
patent: 2003/0050436 (2003-03-01), Coy et al.
patent: 2003/0171561 (2003-09-01), Pillai et al.
patent: 2003/0224998 (2003-12-01), Reubi et al.
patent: 2004/0136906 (2004-07-01), Cappelletti et al.
patent: 2005/0163710 (2005-07-01), Hoffman et al.
patent: 2005/0171014 (2005-08-01), Tarasova et al.
patent: 2006/0067886 (2006-03-01), Hoffman et al.
patent: 0309297 (1989-03-01), None
patent: 0436005 (1995-03-01), None
patent: 0489089 (1996-06-01), None
patent: 0438519 (1998-05-01), None
patent: 1181936 (2002-02-01), None
patent: 0749325 (2002-06-01), None
patent: 1001977 (2005-10-01), None
patent: 89/02897 (1989-04-01), None
patent: 90/03980 (1990-04-01), None
patent: WO91/01144 (1991-02-01), None
patent: 91/02746 (1991-03-01), None
patent: 95/24220 (1995-09-01), None
patent: 1995032741 (1995-12-01), None
patent: WO96/03427 (1996-02-01), None
patent: 98/47524 (1998-10-01), None
patent: 99/62563 (1999-12-01), None
patent: 2000038738 (2000-07-01), None
patent: 00/50059 (2000-08-01), None
patent: 01/52900 (2001-07-01), None
patent: 2001062777 (2001-08-01), None
patent: 2002087631 (2002-11-01), None
patent: 03/072754 (2003-09-01), None
patent: 20040062574 (2004-07-01), None
patent: 2004065407 (2004-08-01), None
Hu et al (Nuclear Medicine and Biology, 2002. vol. 29, pp. 423-430).
Achilefu et al (J. Med. Chem. 2002, vol. 454, pp. 2003-2015).
Hoffman et al (Journal of Nuclear Medicine, 2003, vol. 44, pp. 823-831).
Giblin et al. (1998), Proc. Natl. Aca. Sci., USA, vol. 95, pp. 12814-12818.
Walsh et al., Western Journal of Medicine, vol. 155, pp. 152-163, 1991.
Heppeler et al., Receptor Targeting for Tumor Localization and Therapy with Radiopeptides. Current Medicinal Chemistry 2000, 7:971-994.
Sethi et al., Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo, Cancer Res. May 1, 1992;52(9 Suppl):2737s-2742s.
Halmos, T., Wittliff, J.L., and Schally, A.V., Characterization of bombesin/gastrin releasing peptide receptors on human breast cancer and their Relationship to steroid receptor expression, Cancer Research 55:280-287, 1995.
Kelly, K., Kane, M.A., and Bunn, P.A., “Growth factors in lung cancer: Possible etiologic role and clinical target”, Medical and Pediatric Oncology 19:449-458, 1991.
Jensen, R.T., Mrozinski, J.E., and Coy, D.H., “Bombesin receptor antagonists: Different classes and cellular basis of action”, Recent Results in Cancer Research 129:87-113.
Reile, H., Armatis, P.E., and Schally, A.V., Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells, Prostate, Jul. 1994;25(1):29-38.
Schutte, J., and Seeber, S., “Bombesin antagonists: Experimental and clinical results”, Recent Results in Cancer Research 129:115-129, 1993.
Walsh, J.H., Karnes, W.E., Cuttitta, F., and Walker, A., “Autocrine growth factors and solid tumor malignancy”, Western Journal of Medicine 155: 152-163, 1991.
Leban, et al., Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal DPro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues, J Med Chem. Feb. 18, 1994;37(4):439-45.
Li, et al.; In-Vivo and In-Vitro Characterization of a Rh-105-Tetrathiamacrocycle Conjugate of a Bombesin Analogue, Proceedings of the 43rd Annual Meeting, vol. 37, No. 5, May 1996 Supplement, p. 61.
Zhu, et al.; Binding, internalization, and processing of bombesin by rat pancreatic acini, Bombesin Binding and Internalization, 1991, pp. G57-G64.
Moody, et al.; BW1023U90: A new GRP Receptor Antagonist for Small-Cell Lung Cancer Cells, Peptides vol. 17, No. 8, pp. 1337-1343, 1996.
Moody, et al.; A GRP Receptor Antagonist Which Inhibits Small-Cell Lung Cancer Growth; Life Sciences, vol. 56, No. 7, pp. 521-529, 1995.
Seifert, et al.; No Carrier Added Preparations of ‘3+1’ Mixed-ligand 99mTc Complexes, Appl. Radiat. Isot. vol. 49, Nos. 1-2, pp. 5-11, 1998.
Smith, et al.; In Vivo and In Vitro Characterization of Novel Water-Soluble Dithio-Bisphosphine 99mTc Complexes, Nuclear Medicine & Biology, vol. 24, pp. 685-691, 1977.
Coy et al, “Short Chain Pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic Acinar and swiss 3T3 cells display strong Antimitotic activity” J. Biol. Chem., vol. 264, No. 25, pp. 14691-14697, 1989.
Thomas et al., Antitumoral Activity of Bombesin Analogues on Small Cell Lung Cancer Xenografts: Relationship with Bombesin Receptor Expression, Cancer Res. Sep. 15, 1992;52(18):4872-7.
Radulovic et al., Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice, Acta Oncol. 1994;33(6):693-701.
Qin, et al., Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro, Cancer Res. Feb. 15, 1994;54(4):1035-41.
Qin, et al., Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP, Int J Cancer. Oct. 9, 1995;63(2):257-62.
Cai et al., Potent Bombesin antagonists with C-Terminal Leu-(CH2-N)-Tac-NH2 or its Derivatives, (1994) Proc. Natl. Acad. Sci., 91:12664-12668.
Radulovic, et al., Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi, Int J Pept Protein Res. Dec. 1991;38(6):593-600.
Staley, et al., [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists, Peptides. Jan.-Feb. 1991;12(1):145-9.
Wang et al., Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells, Biochemistry. Jan. 23, 1990;29(3):616-22.
Wang, Knezetic, Schally, Pour, Adrian; Bombesin May Stimulate Proliferation of Human Pancreatic Cancer Cells Through An Autocrine Pathway, Int. J. Can

Affiliated with

Also associated with

Rating

Gastrin releasing peptide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gastrin releasing peptide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastrin releasing peptide compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081290